Background. Depression and anxiety are among the most prevalent disorders in primary care. City dwelling is commonly cited as a risk factor for mental disorders, but epidemiological evidence for this relationship is inconclusive. Objective. To compare the prevalence of antidepressant use, as a proxy for the level of depressive disorders, between patients in Israeli urban and rural communities. Methods. A cross-sectional study, based on data drawn from the registry of the largest health maintenance organization in Israel. The prevalence of antidepressant purchase during 2014 was evaluated for 581 291 patients living in urban and rural communities. Data were also collected for potential confounding variables: age, gender, comorbidity, socioeconomic status and being a holocaust survivor. Results. Results showed higher rates of antidepressant use among patients living in urban (11.8%) compared with rural communities (8.1%; <0.001). A particularly high rate of antidepressant use was found on kibbutz (15.9%), a collective rural community in Israel, compared with both urban and other rural communities. Kibbutz compared with other rural communities: odds ratio (OR) = 1.73, P < 0.001; urban communities compared with non-kibbutz rural communities: OR = 1.21, P < 0.001. A significantly lower rate of antidepressant use was found in urban and rural Arab-majority communities (3.9% and 3.8%, respectively). Conclusions. Antidepressant use varies significantly between different communities in Israel. The highest rate of antidepressant use in our study was found on kibbutz, followed by that in urban communities, with the lowest rates in non-kibbutz rural communities. This difference may derive from different depression rates, stigma of mental illness and awareness of mental disorders.
Introduction
Depression and anxiety are among the most prevalent disorders in primary care. A recent international epidemiology study analysed data from 18 countries and found that the average lifetime and 12-month prevalence of a major depressive episode were respectively 14.6% and 5.5% in high-income and 11.1% and 5.9% in low-to middle-income countries (1) . A review from 2011 of epidemiological studies of mental disorders in Europe found that the 12-month prevalence of anxiety Advance Access publication 3 September 2018 disorders was 14% (2) , and according to large population-based surveys, up to 33.7% of the population are affected by an anxiety disorder during their lifetime (3) . In Israel, a survey that was conducted between 2003 and 2004 showed a lifetime prevalence of depression and anxiety of 17.6%. Depression was the most common mental health disorder with a lifetime prevalence of 10.7% and a 12-month prevalence of 6.4%. General anxiety disorder was the second most common mental health disorder with a lifetime prevalence of 7.2% (4) . Depression and anxiety have a considerable impact on physical, mental and social well-being. The World Health Organization ranks depression as the fourth leading cause of disability worldwide (5) . As a result, it is vital to understand which factors contribute towards the development of these mental health conditions. Sociologic researches have historically linked city dwelling as a potential contributor to mental health issues. Studies that compared the prevalence of mental health disorders between residents of urban and rural communities have shown inconclusive results. Most studies identify a higher rate of mental health disorders, especially depression, among patients living in urban communities. The strongest evidence comes from a meta-analysis published in 2010 that combined published data from 16 countries and reported an odds ratio (OR) of depressive disorder of 1.39 (95% CI: 1.23 to 1.58) in urban compared with rural communities (6) . Other studies from recent years, which were not included in this meta-analysis, also demonstrated a higher rate of mental disorders in urban communities. A Canadian Community Health Survey found lower rates of depression in rural compared with urban communities (OR = 0.76, 95% CI: 0.59 to 0.98). The lower risk of depression among rural dwellers in this study was associated with a stronger sense of community belonging (7) . Two epidemiological surveys from Germany (8) and the Netherlands (9) found that the prevalence of psychiatric disorders gradually increased over five levels of urbanization. These gradually increasing rates of depression and anxiety disorders in parallel with increasing urbanization reinforce the connection between mental health disorders and urban dwelling.
However, other studies have failed to show a connection between mental health and urbanization. In two National Surveys of mental health from the USA, no rural-urban differences were found in diagnosis rates for depression or anxiety disorders (10, 11) . In a Japanese study, the prevalence of depression among the elderly was investigated, and its risk factors were compared between urban and rural areas. The study indicated that the prevalence of depression was almost identical among community-dwelling elderly people regardless of whether they resided in urban or rural areas (12) .
Most of the studies that investigate the connection between mental health disorders and urbanization use population surveys or questionnaires in order to assess the psychiatric status of their participants. Report bias is the main disadvantage of these methods. Psychiatric disorders are a sensitive issue for many people, with perceived stigma, and this could influence participants' decisions to share their symptoms or mental health diagnosis. Other studies examined the prevalence of psychotropic medication use and compared it between urban and rural communities. A Scottish analysis compared psychotropic medication use between patients in urban and rural communities and found a higher rate in urban communities (β = −0.20, P < 0.01) (13) . Another study from Kansas, USA examined urban and rural patterns of antidepressant use among nursing facility residents. The study found that all antidepressants were used more commonly in urban areas (14) .
In Israel, the relationship between mental health disorders, their treatment and urban dwelling has not previously been adequately investigated.
Methods
This is a cross-sectional study, based on data drawn from the registry of Clalit Health Services. Clalit Health Services is the largest health maintenance organization (HMO) in Israel, treating 52% of the population (15) . Its patients are fairly representative of Israel as a whole, and its services are comparable with those provided by other HMOs.
The study received institutional review board approval from the Helsinki Committee of Clalit Health Services. The study data were collected by authorized persons according to the study protocol, and patient anonymity was maintained.
Selection of study subjects
The study population consists of all patients over the age of 18 years, who belonged to two districts in the HMO between 1 January and 31 December 2014. Patients who left the HMO or died during the year of study were excluded.
Measurements
Antidepressant use was defined as the purchase of at least one prescription of antidepressant medication (selective serotonin reuptake inhibitor, serotonin-norepinephrine reuptake inhibitors, norepinephrine reuptake inhibitors, tricyclic antidepressants and atypical antidepressants) in the year of the study. In Clalit Health Services, the medications are dispensed to patients with nominal copayment. Thus, patients do not usually buy their medications outside the HMO. The pharmacies used by the HMO are fully computerized and report to a central repository. These factors ensured that most purchased prescriptions were included in the study.
We obtained the annual rates of antidepressant purchase for patients living in urban and rural communities.
Communities were defined as urban or rural according to the definition of the Israeli Central Bureau of Statistics. Rural communities, such as villages and the kibbutz, are small communities with <2000 citizens. In the past, many were agricultural communities. They are characterized by low construction density and open green spaces. The kibbutz is a rural collective community, unique to Israel, originally run on socialist principles; today most have undergone degrees of privatization. Urban communities in this study are those with >2000 citizens. A city is an urban community with >20 000 citizens. A big city is a city with >200 000 citizens.
The population examined in this study lives in central Israel, with short distances between communities and usually good access to medical treatment in both urban and rural communities. In the communities examined, some are diverse both ethnically and religiously, whereas others are homogeneous.
Data were also collected for potential confounding variables: age, gender, comorbidity, socioeconomic status and being a holocaust survivor. Demographic information of age, gender and being a holocaust survivor was drawn from the electronic medical records of Clalit Health Services. Comorbidity was calculated using the Charlson Comorbidity Index (score 1-5). The Charlson Comorbidity Index reflects both the number and seriousness of the patient's medical conditions in order to predict mortality (16) . This score is calculated by Clalit Health Services' medical division for all primary care patients and is adjusted for age. Socioeconomic status (low, medium, high) was based on the Israeli Central Bureau of Statistics classification of the area in which the primary clinic to which each patient was affiliated was located. It is considered a good proxy of patient socioeconomic status (17) . The vast majority of patients are registered in neighbourhood clinics; thus, the socioeconomic status of clinics reflects that of the patients' place of residence.
Statistical analysis
Our data were analysed using SPSS 22.0 (SPSS Inc., Chicago, IL). The proportions of study participants using antidepressants (yes/no variable) were compared using the chi-square (Chi Sq.) test. If the P value was <0.05, we considered the association statistically significant. Similarly, chi-square was used to identify other factors significantly associated with the type of community. We used logistic regression model analysis in order to determine the unique contribution of community type to the use of antidepressant medications whilst controlling for all other variables. OR and 95% confidence intervals were calculated.
Results
Our study population consists of 581 291 patients; 443 702 of them live in urban communities, and 137 589 of them live in rural communities. The demographic and medical characteristics of the study population are shown in Table 1 . Overall 63 342 (10.9%) of our study population used antidepressant medications in 2014. There was a significantly higher rate of antidepressant use among patients living in urban (11.8%, N = 443 702) compared with rural communities (8.1%, N = 137 589; P < 0.001). An exception is a particularly high rate of antidepressant use (15.9%, N = 13 272), which was found in kibbutz communities. Figure 1 shows the distribution of antidepressant use between different communities in Israel. Table 2 presents results of the logistic regression analysis, showing that patients in kibbutz communities used statistically more antidepressant medications compared with other rural communities: OR = 1.73, P < 0.001. Patients in urban communities used statistically more antidepressant medications compared with non-kibbutz rural communities: OR = 1.21, P < 0.001.
Among Arab-majority communities, there was no difference in antidepressant use between urban and rural communities. A significantly higher rate of antidepressant use was found among Jewishmajority communities compared with Arab-majority communities: OR = 2.3, P < 0.001.
Antidepressant use was linked to other variables as well. Women, older patients, those with greater medical comorbidity, those of higher socioeconomic status and holocaust survivors were more likely to purchase antidepressant medications (Table 2) .
Discussion
This study compared the use of antidepressant medications between different communities in Israel. Our findings demonstrate a higher rate of antidepressant use in urban communities compared with most rural communities. This difference remains statistically significant after removal of the confounding variables: gender, age, socioeconomic status, comorbidity rate and being a holocaust survivor. There are various explanations for the higher rate of antidepressant use in urban communities. One is a higher rate of affective disorders in urban communities compared with rural communities. This explanation is supported by other studies (6-9), as discussed above. Two main hypotheses can explain a higher rate of mental health disorders in urban environments: the 'breeder hypothesis' and the 'drift hypothesis' (18) . The 'breeder hypothesis' is that people in highly urbanized communities suffer from psychiatric disorders because of environmental stressors. Sociological studies point to multiple variables in urban environments that can contribute to the development of mental health disorders. First, the decline in community relationships and social isolation in cities (19) . Second, greater environmental stressors, such as restricted living space, overstimulation, low-quality housing, higher levels of crime (20, 21) , high levels of hostility (22) and higher concentrations of poverty in city centres (23) . Third, more air pollution and noise (24) . And finally, the urban environment has less green spaces. The available research suggests that living in a green environment can have a positive impact on mental health (25, 26) . Some of the impact can be explained by higher physical activity in greener neighbourhoods (27) . The rest of the impact can be explained by the restorative effects of the natural environment itself.
The 'drift hypothesis' assumes that selective migration may take place, resulting in a higher concentration of mentally ill patients in more urbanized environments. However, the number of available studies, and therefore evidence, about urban-rural drift is sparse (28). Other explanations of the higher rate of antidepressant use in urban communities are less awareness and more stigma of mental disorders in rural communities. This can influence both diagnosis of mental disorders and their treatment thus suggesting that true rates of mental health disorders in rural areas are actually higher than those reported. In a study aimed at exploring rural family physicians' attitudes towards depression, the physicians reported that depression is sometimes not diagnosed even when recognized because of perceived stigma, time pressures, financial issues and barriers to care including fewer resources (29) . Stigma may be a particularly important barrier to mental health care in rural communities where lack of anonymity increases the probability that someone who seeks care will be recognized in their local community and perhaps labelled negatively. Rost K et al. examined rural-urban differences and the stigma associated both with depressive symptoms and with seeking treatment for depression. Their findings indicated that rural residents with a history of depressive symptoms labelled people who sought professional help for the disorder somewhat more negatively than their urban counterparts. Logistic models controlling for sociodemographic characteristics demonstrated that the more negative the labelling, the less likely depressed rural residents were to seek professional help (30) .
Antidepressant prescription and use can also be influenced by urban-rural variations in prescribing behaviour (14) . Prescribing patterns are influenced by several factors, including the demographic, educational and cultural characteristics of both doctors and patients. There is also a theory that new information may reach or be adopted later in rural areas than in urban areas. Urban-rural differences in prescribing patterns have been identified for several health conditions; however, many such reports involve special technical or consultative services that are less accessible in rural areas (31, 32) . Less has been reported about urban-rural patterns for commonly used oral medications. Moreover, today's doctors are influenced by practice guidelines, and medical information is accessible online. These factors would be expected to reduce differential prescribing behaviours (14) .
The diagnosis and treatment of mental health disorders can also be influenced by access to medical services. However, in our study in central Israel, with short distances of under 20 kilometres between communities, even the rural ones, the possibility of underdiagnosis and treatment because of lack of access to medical services is reduced.
The highest rate of antidepressant use in our study was found in the kibbutz. This rate was significantly higher than the rate in the rest of the rural communities and also higher than the rate of antidepressant use in the cities. In a literature review, we found only a few studies researching the connection between kibbutz lifestyle and mental health. One study followed the mental health of 100 children, some of them with a family history of schizophrenia, living in the kibbutz and in the city. The study found identical rates of schizophrenia, but a higher rate of depression among children raised in the kibbutz (33, 34) .
Another study compared the prevalence of psychological problems in adults who were raised in kibbutz or non-kibbutz communities in Israel. The study found a higher rate of psychological problems and psychological treatment in kibbutz members. The authors explained these differences as due to both a higher rate of mental health disorders in the kibbutz and greater availability of mental health services which are paid for or provided by the kibbutz (35) . Higher rate of depression and antidepressant use in kibbutz communities may be the consequence of the intense communal life: The kibbutz is a relatively small closed community with few opportunities for privacy and individualism. This can contribute to the development of depression and anxiety in some people. Additionally, in recent decades, many of the kibbutz communities have undergone a process of privatization. This may cause stress and financial problems to some of the kibbutz members and can contribute to the development of depression and anxiety. Arab citizens of Israel in our study, in both urban and rural communities, were substantially less likely than Israeli Jews to purchase antidepressants. Similar results were found in another study that checked the characteristics associated with purchasing antidepressant and antianxiety medications in Israel from 2006 (17) . The similar rates of antidepressant use in urban and rural Arab communities may point to rural environmental variables being maintained also in urban Arab communities. The statistically lower overall rate of antidepressant use may be due to cultural differences, perceived stigma of mental illness in Arab communities (36, 37) and difficulty in accessing appropriate care (38) . Whilst the numbers of both mental health professionals and clinic visits are increasing, there are still disproportionally few Arabic-speaking psychiatrists and psychologists in Israel (39) .
Our study is important for family physicians as it contributes to the knowledge of potential causes for the development of anxiety and depression, common conditions in primary care. Our findings reinforce the connection between the environment we live in and our health.
Our study also raises the possibility that the diagnosis and treatment of depression and anxiety may be influenced by factors such as stigma, awareness of mental disorders and different doctors' prescribing patterns. Family doctors should keep these factors in mind while treating patients with psychological symptoms in both urban and rural communities.
Finally, we present here some of the limitations of our study: First, this is a cross-sectional study. We could not control for selection bias, in particular, that those with better mental health elected to live in more rural locations, and we could not assess the impact of living environment over time. Second, in this study, we examined the proportion of antidepressant use. This may cause bias because, as discussed above, antidepressant use may be influenced by other factors than the prevalence of depression and anxiety, such as awareness of mental disorders, stigma and variations in prescribing behaviour between urban and rural communities. Third, antidepressant medications can be used for purposes other than treating depression and anxiety, such as pain relief and sleep disturbances. As a result, we cannot directly link rates of antidepressant use with rates of diagnosis of depression and anxiety. However, use of these medications for other purposes is likely to have occurred in all the population studied and is therefore unlikely to have influenced the comparative results between urban and rural communities. Nevertheless, the measure of antidepressant use also has advantages. It is dependent neither on self-reported psychiatric symptoms or mental status, nor on documentation of mental illness in the medical records. Studies found that antidepressant use appears to be a useful proxy indicator for all types of depressive symptoms (40) and that psychotropic medication use enables an evaluation of the volume of mental health issues (13) .
Conclusions
This study showed significantly higher rates of antidepressant medication use in urban as compared with rural communities. These results may reflect different disease prevalence, stigma of mental illness, awareness of mental disorders or variations in prescribing behaviour. Further research is needed to explore better the connection between urban dwelling and the development of depression and anxiety that was implied by our study.
